Utah’s Myriad Genetics Ramps up Gene Patenting Dispute
By Tom Harvey,
The Salt Lake Tribune
| 12. 09. 2013
In the wake of a
case that went all the way to the U.S. Supreme Court, Salt Lake City-based Myriad Genetics is now enveloped in a new spate of lawsuits over its gene patents, this time sparring with companies that want to erode its dominant position in testing of genes related to breast and ovarian cancer.
At stake for Myriad is whether the company can maintain the parts of its patents that the Supreme Court and a lower appeals court did not invalidate.
Myriad uses the patents for tests it now sells exclusively. The sale of those tests accounted for 75 percent of Myriad’s $613 million in revenue in the fiscal year that ended June 30.
The risks for the company are underscored by its shares, which have generally declined in price since Dec. 2 when one of its potential competitors sued and reports surfaced that the Centers for Medicare & Medicaid Services would cut what the government pays Myriad for tests related to the genes labeled BRCA1 and BRCA2.
The company’s shares finished Nov. 29 at $29.75, then...
Related Articles
By Eric Schmidt, TIME | 04.16.2024
Imagine a world where everything from plastics to concrete is produced from biomass. Personalized cell and gene therapies prevent pandemics and treat previously incurable genetic diseases. Meat is lab-grown; enhanced nutrient grains are climate-resistant. This is what the future could...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Carey Gillan, UnSpun | 03.18.2024
A Mexican standoff with the United States turned into a Mexican smack-down this month with the release of Mexico’s formal rebuttal to US efforts to overturn limits Mexico has ordered on the use of genetically modified (GM) corn and the...
By Billy Perrigo, TIME | 03.11.2024
The U.S. government must move “quickly and decisively” to avert substantial national security risks stemming from artificial intelligence (AI) which could, in the worst case, cause an “extinction-level threat to the human species,” says a report commissioned by the U.S...